The Middle East Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Gazette.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 31, 2026

Mar. 31, 2026

Inspira Technologies Terminates ATM and SEPA Equity Facilities to Prepare for Next Strategic Phase

GlobeNewswire

Mar. 31, 2026

Online Trading Expo 2026 Announces Hong Kong Event for Global Fintech and Brokerage

GlobeNewswire

Mar. 31, 2026

Adcytherix Doses First Patient in Phase 1 Trial of ADCX-020 and Strengthens Leadership to Support Next Phase of Growth

GlobeNewswire

Mar. 31, 2026

Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies

GlobeNewswire

Mar. 31, 2026

Pheast Therapeutics Advances PHST001, an IgG4 Anti-CD24 Monoclonal Antibody, into Phase 1b Combination Cohorts

GlobeNewswire

Mar. 31, 2026

Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

GlobeNewswire

Mar. 31, 2026

Proxygen Appoints Chiara Conti, Ph.D. as Chief Scientific Officer to Drive Clinical Translation and Expand Induced Proximity Platform Beyond Degradation

GlobeNewswire

Mar. 31, 2026

1287405 B.C. Ltd and Monteoro Minerals Announce Proposed Go-Public Transaction and C$17 Million Financing

GlobeNewswire

Mar. 31, 2026

NervGen Pharma Reports Full Year 2025 Financial Results and Provides Business Updates

GlobeNewswire

Mar. 31, 2026

BOS Reports Financial Results for the Fourth Quarter and Full Year 2025

GlobeNewswire

Mar. 31, 2026

Rio Silver Closes $3.0M Private Placement with Eric Sprott as Lead Investor

GlobeNewswire

Mar. 31, 2026

InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium

GlobeNewswire

Mar. 31, 2026

Odysight.ai® Announces Dual Listing on the Tel Aviv Stock Exchange

GlobeNewswire

Mar. 31, 2026

4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK

GlobeNewswire

Mar. 31, 2026

Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders

GlobeNewswire

Mar. 31, 2026

Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA

GlobeNewswire

Mar. 31, 2026

Aya Gold & Silver Reports Record Results for Q4-2025 and Full Year 2025

GlobeNewswire

Mar. 31, 2026

Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology

GlobeNewswire

Mar. 31, 2026

SCYNEXIS Announces $40.0 Million Private Placement

GlobeNewswire

Mar. 31, 2026

SCYNEXIS Completes Transformative Acquisition of PXL-770, an innovative, highly selective, direct AMPK activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

GlobeNewswire